Spermosens AB (publ) (SPERM.ST)
Stockholm · SEK · Healthcare · Diagnostics & Research
SEK 0.0084 (+2.44%) as of
Key statistics
- Market cap
- 26.65M
- EPS (TTM)
- -0.0000
- Dividend yield
- 0.00%
- 52-week range
- 0.0044 – 0.0120
- Beta
- 0.15
- Profit margin
- 0.00%
- Volume
- 526.85k
About Spermosens AB (publ)
Spermosens AB (publ) provides diagnostic health care products and services in Sweden. The company offers devices for male infertility for fertility diagnostics and treatments for the IVF market. It develops JUNO-Checked, that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB (publ) was incorporated in 2018 and is headquartered in Lund, Sweden.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Lund, Sweden
- Employees
- 4
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.